Lipigon Pharmaceuticals AB (LPGO) — Cash Flow Quality Index

Latest as of June 2023: -1.46x

Lipigon Pharmaceuticals AB (LPGO) has a Cash Flow Quality Index of -1.46x as of June 2023. Operating cash flow of Skr-10.38 Million is below net income of Skr7.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Lipigon Pharmaceuticals AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.46x

Operating CF / Net Income

Operating Cash Flow

Skr-10.38 Million

SEK

Net Income

Skr7.13 Million

SEK

Data as of

Jun 2023

Most recent filing

Annual Cash Flow Quality Index for Lipigon Pharmaceuticals AB (None–None)

Year-by-year earnings quality comparison for Lipigon Pharmaceuticals AB.

Year	Quality Index	Operating CF (SEK)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.